You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ANTX Sale Disclosure
Readnour Robin Shane · SEC Form 4 · Filed Aug 19, 2026
Sale
Calculated transaction value
$112.39K
Readnour Robin Shane Director
ANTX
Transaction date
Aug 17, 2026
Public filing date
Aug 19, 2026
Filing lag
Filed 2 days later
ANTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 18,706 shares @ $6.01
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-357225
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$212.7K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| An2 Therapeutics, Inc. ANTX | Sale | Aug 17, 2026 | $100.31K |
| An2 Therapeutics, Inc. ANTX Current | Sale | Aug 17, 2026 | $112.39K |